What is ARS Pharmaceuticals, Inc.'s accounts receivable?

ARS Pharmaceuticals, Inc. (SPRY) reported accounts receivable of $28.66M in Q1 2026.

How has ARS Pharmaceuticals, Inc.'s accounts receivable changed year-over-year?

ARS Pharmaceuticals, Inc.'s accounts receivable increased by 208.1% year-over-year, from $9.3M to $28.66M.

What does accounts receivable mean?

Amounts owed by customers for goods delivered or services performed, net of allowances for doubtful accounts. A key working capital component.

ARS Pharmaceuticals, Inc. SPRY Accounts Receivable

Accounts Receivable at other companies

Amneal Pharmaceuticals, Inc.AMRX

-$44.01M-108%

ViatrisVTRS

$2.58B-0.3%

AMP

Amphastar PharmaceuticalsAMPH

$147.85M+2.2%

Catalyst PharmaceuticalCPRX

$130.83M+83.6%

Eton Pharmaceuticals, Inc.ETON

$13.41M-18.2%

Other financials

Income statement

See full

Revenue$22.7M+184%

Operating income-$60.1M-61.8%

Net income-$60.6M-78.6%

EPS (diluted)-$0.61-74.3%

Balance sheet

See full

Cash & equivalents$24.3M-39.0%

Total debt$96.5M+132,122%

Total equity$61.3M-73.2%

Total assets$287.6M-12.1%

Cash flow

See full

Operating cash flow-$44.9M-10.3%

CapEx--100%

Free cash flow-$44.9M-10.1%

Valuation

See full

Market cap$796.41M-48.7%

Enterprise value$868.61M-42.6%

P/S8.1×-7.9×

Profitability

See full

Operating margin-204.5%—

Net margin-200%-219pp

FCF margin-177.1%-206pp

Returns & leverage

See full

Return on equity-136.4%-144pp

Debt / equity1.6×+1.6×

Current ratio4.9×-6.1×

Where this comes from

Reported directly by ARS Pharmaceuticals, Inc. in its filing.

Tagged under the XBRL concept us-gaap:AccountsReceivableNetCurrent.

The official record: ARS Pharmaceuticals, Inc.’s 10-Q, filed May 15, 2026, on SEC EDGAR. View the filing →

Ask your AI about ARS Pharmaceuticals, Inc.'s accounts receivable.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is ARS Pharmaceuticals, Inc.'s accounts receivable?: ARS Pharmaceuticals, Inc. (SPRY) reported accounts receivable of $28.66M in Q1 2026.
How has ARS Pharmaceuticals, Inc.'s accounts receivable changed year-over-year?: ARS Pharmaceuticals, Inc.'s accounts receivable increased by 208.1% year-over-year, from $9.3M to $28.66M.
What does accounts receivable mean?: Amounts owed by customers for goods delivered or services performed, net of allowances for doubtful accounts. A key working capital component.